Posts

Showing posts with the label precision nutrition

Precision Nutrition for Cancer: Can Diet Be Personalized by Tumor Genetics?

Image
Introduction: Beyond "Eat Healthy" in Oncology The dietary advice most cancer patients receive from their oncologists — if they receive any at all — amounts to a gentle recommendation toward the Mediterranean diet, adequate protein, and avoiding ultra-processed foods. This advice is not wrong. It is simply insufficient. We now know that a breast cancer with a PIK3CA mutation, a colorectal cancer driven by microsatellite instability, and a glioblastoma harbouring an IDH1 mutation represent fundamentally different diseases — not just histologically, but metabolically. Each has a distinct pattern of fuel dependency, enzyme upregulation, and pathway addiction. If this is true — and the evidence increasingly says it is — then a single dietary template for all cancer patients is not only imprecise but potentially counterproductive. The emerging field of precision nutrition for cancer asks a direct question: can we match dietary composition to tumour genetics? This article examines...

Genomics, Nutrigenomics and Precision Oncology: The Future of Personalized Cancer Care (2026)

Image
Modern oncology is rapidly evolving from a “one-size-fits-all” model into a far more individualized approach known as precision oncology. At the center of this transformation are: Genomics Nutrigenomics Biomarker testing Tumor sequencing AI-driven molecular analysis Precision nutrition Together, these fields are reshaping how clinicians understand cancer risk, treatment response, metabolism, inflammation, and even dietary interventions. The convergence of cancer genomics and personalized nutrition may become one of the defining themes of next-generation oncology. Genetics vs Genomics: Why the Difference Matters Many people use the terms “genetics” and “genomics” interchangeably, but they are not the same. ( Cancer.org ) Genetics Genetics focuses primarily on individual inherited genes passed down through families. Examples include: BRCA1 and BRCA2 mutations Lynch syndrome Familial adenomatous polyposis (FAP) These inherited mutations are often called germline mutations. They may increa...

Precision Nutrition and Cancer: The Future of Personalized Oncology?

Image
Key Takeaways Precision nutrition aims to personalize dietary strategies using genetics, metabolism, biomarkers, and microbiome data. Metabolic dysfunction is increasingly linked to cancer biology and treatment response. The gut microbiome may influence immunity and immunotherapy outcomes. Different cancer patients may require very different nutritional approaches. Precision nutrition may eventually become part of systems oncology and personalized medicine. Much of the science remains early-stage and evolving. Cancer treatment is rapidly evolving beyond the traditional “one-size-fits-all” approach. Precision oncology already uses: genomic testing, biomarkers, immunotherapy, and molecular profiling to tailor treatment to individual patients. Now, researchers are beginning to ask a new question: Could nutrition also become personalized based on a patient’s genes, metabolism, microbiome, and tumor biology? This emerging field is known as precision nutrition . Precision nutrition aims to u...

Archive

Show more